• Return to Headlines

After Yesterday's Rally of 3.44% Shares Could Potentially Pullback

By David Diaz

Alnylam Pharmaceuticals (NASDAQ:ALNY) traded in a range yesterday that spanned from a low of $72.75 to a high of $76.33. Yesterday, the shares gained 3.4%, which took the trading range above the 3-day high of $74.17 on volume of 468,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

SmarTrend recommended that subscribers consider buying shares of Alnylam Pharmaceuticals on July 7th, 2016 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $61.09. Since that recommendation, shares of Alnylam Pharmaceuticals have risen 19.1%. We continue to monitor ALNY for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Alnylam Pharmaceuticals share prices have moved between a 52-week high of $140.00 and a 52-week low of $49.96 and are now trading 50% above that low price at $74.84 per share. Over the past week, the 200-day moving average (MA) has gone down 1.7% while the 50-day MA has remained constant.

Keywords: rebounders alnylam pharmaceuticals

Ticker(s): ALNY